Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
Non-Consolidated Financial Results (Japanese GAAP) for the Six Months Ended June 30,2025
Supplementary Information for Financial Results Q2 FY12/25
Supplementary Information for Financial Results Q1 FY12/25
Non-Consolidated Financial Results (Japanese GAAP) for the Three Months Ended March 31,2025
[Updated] Non-Consolidated Financial Results (Japanese GAAP) for the Fiscal Year Ended December 31, 2024
Announcement of a collaborative exploratory research agreement with OmniAb, Inc.
Non-Consolidated Financial Results (Japanese GAAP) for the Fiscal Year Ended December 31, 2024
Supplementary Information for Financial Results FY12/24
Announcement of Paper Publication on Cancer Immunotherapy Using Tribody Technology
Announcement of Paper Publication on the First Part of the CBA-1205 Phase I Clinical Study
Announcement of Paper Publication on CBA-1205 Non-Clinical Data
Extension of the Master Services Agreement with Chugai Pharmaceutical Co., Ltd.
[Revised] Chiome Announces Exclusive Licensing Agreement for Anti-CX3CR1 Antibody
Chiome Announces Exclusive Licensing Agreement for Anti-CX3CR1 Antibody
Non-Consolidated Financial Results (Japanese GAAP) for the Nine Months Ended September 30, 2024
Supplementary Information for Financial Results Q3 FY12/24